By The Fresh Toast's Kate-Madonna Hindes, provided exclusively to Benzinga Cannabis.
With the anti-inflammation properties of CBD and marijuana, it’s only a matter of time before scientists start experimenting with THC’s effects on the body and its genomes.
Could marijuana and CBD be helped by a genomic parasite to decrease inflammation and viruses?
Researchers at the CECAD Cluster of Excellence in Aging Research of the University of Cologne, University of Texas Health Science Center and the Francis Crick Institute in London have made a significant discovery that offers insight into targeting viruses and inflammation alike through identifying a key protein called, ZBP1.
Published in the journal Nature, the scientists found that ZBP1, a protein best known for defending against incoming viruses, is activated by sensing an unusual form of cellular genetic material (Z-nucleic acids), leading to cell death and inflammation.
Found in Z-nucleic acids, ZBP1 is a cellular genetic material; double-strained DNA and RNA molecules with an, “unusual left-handed double helix structure.” Discovered over 4 decades ago, scientists have been attempting to understand how the protein unlocks a feature that harms viruses in its path. Once ZBP1 is activated, it can “sense” the genetic make-up of viruses, identifying threats and activating a kill sequence not only when a virus is present but when it meets its kryptonite: RIPK1, a protein stopping ZBP1.
ZBP1, not only seems to have a hand in helping the body fight viruses but seems to offer positive effects on inflammatory diseases such as arthritis. Experimenting on models of mice, researchers were able to showcase that the, “ZBP1 protein binds to double-stranded RNA,” explained Manolis Pasparakis, a professor in the study. “Just like during viral infection, sensing of Z-RNA produced by endogenous retroelements by ZBP1 could provide a potent trigger for cell death and inflammation, and cause disease.
RELATED: Cannabis 101: How To Know If The Marijuana You're Buying Is High Quality
These are early days and we have a long way to go, but understanding the underlying mechanisms may one day lead to novel therapies for human diseases.”
Photo by pcess609/Getty Images
RELATED: This Telemedicine Start-Up Believes Virtual Health Care Is Here To Stay
With the anti-inflammation properties of CBD and marijuana, it’s only a matter of time before scientists start experimenting with THC’s effects on the body and its genomes. Cited as a “novel anti-inflammatory,” cannabis has been researched for decades for its ability to heighten the body’s immune system and relax inflammation. A 2009 study published in the peer-reviewed journal Future Medicinal Chemistry, stated that, “The cannabinoid system has been shown both in vivo and in vitro to be involved in regulating the immune system through its immunomodulatory properties. Cannabinoids can either directly inhibit tumor growth or suppress inflammation and tumor angiogenesis.”
One thing is certain: With new medical research comes the ability to deeper understand the human body’s genetic makeup, offering key insights to how cells react. It’s a matter of if, not when scientists unlock the human body’s many secret abilities.
Photo by Sefa kart/Getty Images
Noticias sobre cannabis en Español en El Planteo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.